SyntheticMR Q2 operating loss narrows to SEK 6.5 million; net sales rise 13% to SEK 14 million yr/yr

Reuters2026/08/25 06:32

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

SyntheticMR posted Q2 net sales of SEK 14 million, up 13% year over year.
Operating loss narrowed to SEK 6.5 million; net loss improved to SEK 6.1 million.
Earnings per share rose to a loss of SEK 0.06; operating cash flow fell to minus SEK 2.6 million.
Cash and cash equivalents climbed to SEK 28.3 million at period-end.
cMRI ARIA received regulatory clearance in the UK and Switzerland; FDA review in the US continued under standard procedures.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SyntheticMR AB published the original content used to generate this news brief via Cision (Ref. ID: 202608250232BITN____UKPR__SV_20260820-BIT-9997-0) on August 25, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

SyntheticMR Q2 operating loss narrows to SEK 6.5 million; net sales rise 13% to SEK 14 million yr/yr

You may also like

Crypto prices